Soleno Therapeutics Inc (SLNO)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

1235 RADIO ROAD REDWOOD CITY, CA 94065

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.

Data as of 2021-09-19 12:56:52 -0400
Market Cap75.771 Million Shares Outstanding79.759 Million Avg 30-day Volume508.77 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.85 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.69147 52-week High/Low3.36 / 0.8 Next Earnings Date2021-10-27 Price to Cash FLow (P/CF) -8.2694
Data provided by IEX Cloud
View SEC Filings from SLNO instead.

View recent insider trading info

Funds Holding SLNO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLNO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

11.2 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACKANESS JAMES H CHIEF FINANCIAL OFFICER

  • Officer
27,295 2021-09-13 2

MARIO ERNEST

  • Director
1,349,909 2021-07-30 6

HARRIS WILLIAM G

  • Director
90,822 2021-07-30 6

VOLCK BIRGITTE

  • Director
52,622 2021-07-30 6

MELINCOFF GWEN A

  • Director
31,862 2021-06-01 2

SINCLAIR ANDREW

  • Director
31,862 2021-06-01 2

ANISH BHATNAGAR CHIEF EXECUTIVE OFFICER

  • Officer
409,260 2021-01-23 3

YEN KRISTEN SEE REMARKS

  • Officer
66,492 2021-01-23 3

HIRANO PATRICIA C SEE REMARKS

  • Officer
119,104 2021-01-23 3

SCHULER JACK W

  • 10% Owner
9,707,848 2020-12-07 1

FEINBERG LARRY N

ORACLE PARTNERS LP

  • * SEE REMARKS* SEE REMARKS
No longer subject to file 2020-09-25 1

COLLINSON STUART J

  • Director
1,018 2020-07-31 0

ABINGWORTH LLP

  • 10% Owner
10,302,602 2020-06-26 0

VIVO VENTURES V, LLC

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

  • 10% Owner
No longer subject to file 2019-12-02 0

BIOASIA MANGEMENT LLC

BIOASIA INVESTMENTS IV LLC

  • 10% Owner
78,798 2019-05-17 0

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-24 0

FEINBERG LARRY N

  • 10% Owner
3,683,195 2018-12-19 1

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-15 0

DALAL RAJEN

  • Director
0 2018-06-11 0

SHAH MAHENDRA

  • Director
0 2018-06-11 0

GLASHEEN JAMES WALTER

  • Director
0 2018-06-11 0

TP MANAGEMENT VII LLC

TECHNOLOGY PARTNERS FUND VII LP

TECHNOLOGY PARTNERS AFFILIATES VII LP

  • 10% Owner
8,328,900 2018-03-07 0

ENGELSEN STEINAR J

  • Director
No longer subject to file 2018-02-05 0

ENGLEMAN EDGAR

  • Director
  • 10% Owner
No longer subject to file 2018-02-05 0

KIRNON STEPHEN

  • Director
No longer subject to file 2018-02-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
2,388,060 2017-12-15 0

VIVO VENTURES V, LLC

  • 10% Owner
14,286,694 2017-10-02 0

O'TOOLE DAVID D

  • Director
0 2017-04-19 0

FORWARD V ASSOCIATES LLC

FORWARD VENTURES V LP

  • 10% Owner
7,173,976 2017-03-07 0

WONDKA ANTHONY SEE REMARKS

  • Officer
0 2016-06-08 0

ALEXANDER W JAMES

  • Director
No longer subject to file 2016-03-28 0

EBBERS ED SEE REMARKS

  • Officer
0 2015-05-15 0

PHELPS GINA VICE PRESIDENT OF SALES

  • Officer
0 2015-01-11 0

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

VIVO VENTURES V, LLC

BDF IV ANNEX FUND LP

BIOTECHNOLOGY DEVELOPMENT FUND IV LP

BIOTECHNOLOGY DEVELOPMENT FUND IV AFFILIATES LP

BIOASIA INVESTMENTS IV LLC

BIOTECHNOLOGY DEVELOPMENT FUND II LP

BIOASIA MANGEMENT LLC

KUNG FRANK

  • 10% Owner
609,839 2014-11-18 0

VIVO VENTURES FUND V, L.P.

CHA ALBERT

ENGLEMAN EDGAR

  • Director
  • 10% Owner
609,839 2014-11-18 0

TEKNOINVEST VIII KS

TEKNOINVEST VIII B (GP) AS

TEKNOINVEST VIII GP KS

  • 10% Owner
198,565 2014-11-12 0

NABHAN ANTOUN SEE REMARKS

  • Officer
0 2014-11-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MACKANESS JAMES H - Officer CHIEF FINANCIAL OFFICER

2021-09-14 18:26:06 -0400 2021-09-13 P 11,235 $0.89 a 27,295 direct 1.6556 -0.1104 4.8565 3 -1.2141 4

HARRIS WILLIAM G - Director

2021-08-03 16:05:42 -0400 2021-07-30 A 16,484 a 96,032 direct 1.3584 -2.8213 -3.7618 1.4629 4 -16.1964 12

VOLCK BIRGITTE - Director

2021-08-03 16:05:50 -0400 2021-07-30 A 14,010 $0.91 a 52,622 direct 1.3584 -2.8213 -3.7618 1.4629 4 -16.1964 12

HARRIS WILLIAM G - Director

2021-08-03 16:05:42 -0400 2021-07-30 F 5,210 $0.91 d 90,822 direct 1.3584 -2.8213 -3.7618 1.4629 4 -16.1964 12

MARIO ERNEST - Director

2021-08-03 16:05:49 -0400 2021-07-30 A 21,978 $0.91 a 1,349,909 direct 1.3584 -2.8213 -3.7618 1.4629 4 -16.1964 12

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SOLENO THERAPEUTICS INC SLNO 2021-09-23 22:15:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 21:45:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 21:15:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 20:45:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 20:15:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 19:45:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 19:15:03 UTC -1.3185 1.3885 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 18:45:04 UTC -1.3374 1.4074 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 18:15:03 UTC -1.3374 1.4074 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 17:45:03 UTC -1.3374 1.4074 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 17:15:03 UTC -1.3374 1.4074 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 16:45:03 UTC -1.4323 1.5023 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 16:15:03 UTC -1.4323 1.5023 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 15:45:03 UTC -1.4323 1.5023 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 15:15:03 UTC -1.4323 1.5023 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 14:45:03 UTC -1.3762 1.4462 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 14:15:03 UTC -1.3762 1.4462 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 13:45:03 UTC -1.3762 1.4462 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 13:15:03 UTC -1.3762 1.4462 650000
SOLENO THERAPEUTICS INC SLNO 2021-09-23 12:45:03 UTC -1.3762 1.4462 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments